logowsbdaily | Thu, 21 Oct 2021 07:34:42 EST Where you find Tomorrow’s Hot Stocks Yesterday! 

NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.

Ocugen, Inc.
(OCGN)

Ocugen, Inc.
263 Great Valley Parkway
Suite 160
Malvern, PA 19355
United States
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fu... Read More

Summary & Charts

Price$ 8.78+0.45 (+5.4%)
Day's Range$ 8.41 - 9.10 
Previous Close$ 8.33
Market Cap$ 1.22B USD
Short Interest %N/A
FloatN/A
OutstandingN/A
ExchangeNasdaqCM
IndustryBiotechnology
SectorHealthcare
Volume17.93M
Avg. Volume (20 day)23.48M
Rel. Volume (20 day)0.76
Rel. Volume (3 month)1.12
RatingBNeutral
DCFN/AStrong Buy
Debt/Equity6.74 %Neutral
ROE-95.12 %Sell
ROA-38.06 %Sell
P/E-36.31 %Strong Sell
P/B14.75 %Strong Buy
DateOpenHighLowCloseChangeVolumeR. Vol. (20d)R. Vol. (3m)Mentions
Oct 20, 2021$ 8.50$ 9.10$ 8.41$ 8.78+0.4517,929,1590.761.1213
Oct 19, 2021$ 8.24$ 8.66$ 8.23$ 8.33+0.0712,006,0520.520.7312
Oct 18, 2021$ 8.14$ 8.81$ 8.10$ 8.26-0.4023,251,8311.031.4117
Oct 15, 2021$ 10.06$ 10.07$ 8.56$ 8.66-1.3944,174,0672.012.7025
Oct 14, 2021$ 8.90$ 10.60$ 8.81$ 10.05+0.8272,861,5273.564.5585
Oct 13, 2021$ 8.78$ 9.32$ 8.32$ 9.23+0.1236,222,8452.102.3438
Oct 12, 2021$ 8.22$ 9.47$ 8.01$ 9.11+1.42104,797,1336.476.87126
Oct 11, 2021$ 7.08$ 7.75$ 6.96$ 7.69+0.6216,007,0321.331.1362
Oct 08, 2021$ 7.11$ 7.37$ 7.01$ 7.07-0.0210,434,4490.690.7016
Oct 07, 2021$ 6.85$ 7.12$ 6.78$ 7.09+0.297,556,8590.510.4810
Oct 06, 2021$ 6.83$ 7.01$ 6.79$ 6.80-0.137,731,2990.520.477
Oct 05, 2021$ 7.25$ 7.59$ 6.72$ 6.93+0.1833,891,3762.322.0425
Oct 04, 2021$ 7.02$ 7.04$ 6.72$ 6.75-0.239,504,5040.720.5810
Oct 01, 2021$ 7.15$ 7.16$ 6.75$ 6.98-0.209,906,9030.760.604
Sep 30, 2021$ 6.87$ 7.24$ 6.85$ 7.18+0.366,852,1750.540.413
Sep 29, 2021$ 7.21$ 7.24$ 6.77$ 6.82-0.3211,461,0600.900.683
Sep 28, 2021$ 7.49$ 7.50$ 7.11$ 7.14-0.5313,164,0861.050.781
Sep 27, 2021$ 7.59$ 7.95$ 7.54$ 7.67+0.1410,631,8030.870.633
Sep 24, 2021$ 7.53$ 8.08$ 7.52$ 7.53-0.0815,094,4951.260.8918
Sep 23, 2021$ 7.57$ 7.63$ 7.46$ 7.61+0.116,078,9010.530.3611

News

The latest news about Ocugen, Inc. (OCGN).

Pulse2 | 2021-10-20 06:44:56
The stock price of Ocugen, Inc. (NASDAQ: OCGN) increased by over 5% pre-market today. This is why it happened.
The Motley Fool | 2021-10-20 06:02:00
They've risen too far, too quickly.
InvestorPlace | 2021-10-19 16:49:16
OCGN stock has suffered as a Covid-19 vaccine latecomer, but news that Covaxin won emergency approval in India sent shares soaring. The post Ocugen Surged on Its Covid Vaccine Emergency Approval in India appeared first on InvestorPlace.
The Motley Fool | 2021-10-19 11:15:00
There is a lot of uncertainty surrounding this biotech's prospects.
GlobeNewsWire | 2021-10-19 08:34:00
MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that its head of Research and Development, Arun Upadhyay, PhD, will present pre-clinical data demonstrating how the company's second modifier gene therapy candidate, OCU410, could potentially be an effective therapeutic for Dry Age-related Macular Degeneration (Dry AMD).
InvestorPlace | 2021-10-19 06:00:36
Highly volatile, with a tendency to make unwarranted moves higher, it's best to not go long (or short) OCGN stock. The post This Ocugen Stock Rally Makes Little Sense, But Watch Out Going Short appeared first on InvestorPlace.
The Motley Fool | 2021-10-18 13:49:16
These COVID-19 vaccine developers are all moving in response to strong late-stage results for Valneva's VLA2001.

Earnings

DateTimeEPS ExpectedEPS Reported%Revenue ExpectedRevenue Reported%
2021-11-04BMO-0.04----------
2021-08-06BMO-0.03-0.13333.33%------
2021-05-07BMO0.5-0.04-108%78M----
2020-11-06BMO-0.02-0.07250%------
2020-08-14BMO-0.04-0.19375%9K43K375.03%
2020-05-11BMO-0.05-0.0739.99%------
2020-03-27BMO-0.144.133050%------
2019-11-12BMO------------

Due Diligences

These posts should include more in-depth research by the poster about the specific company, sector or trade idea. Including any sources and citations.

Nefarious Citadel increases CALL options by 487%! $OCGN 🚀🌕

These guys are the market makers for 50% of retail. I'm sure they understand the flow of things and see what's coming. BOOM BOOM candles. [Screenshotted from Fintel](https://preview.redd.it/wlevqm1hybp71.png?width=1276&format=png&auto=webp&s=00697191c1dd570466cf619951501abe91466c43) If... Read More

77 comments | 66 votes
thumbnail
$OCGN - either we fly to tendyheaven or back to Wendys we go!

This is it apes, Ocugen's Covaxin (a covid vaccine with an old school technology as it is using an inactivated virion), in partnership with Bharat Biotech of India, is awaiting EUA/EUL grant from WHO and SAGE, and its been said that it could be anytime this week to Oct. 5. Now, the big question is,... Read More

Top Discussions

These are the top discussions over the last 24-hours that mention the OCGN stock ticker symbol.

What Are Your Moves Tomorrow, October 21, 2021

What are your moves tomorrow? Please keep the shitposting at a slow boil. ^Navigate ^WSB|^We ^recommend ^best ^daily ^DD :--|:-- **Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sor... Read More

Daily Discussion Thread for October 21, 2021

Your daily trading discussion thread. Please keep the shitposting to a minimum. ^Navigate ^WSB|^We ^recommend ^best ^daily ^DD :--|:-- **Discussion** | [All](https://reddit.com/r/wallstreetbets/sear... Read More


Unusual Option Activity

Option contracts that are trading at a significantly higher volume relative to the contract's open interest. These might provide some insight into what "smart money" is doing with large volume orders.

TypeStrikeExp DateDTEBidAskLastVolumeOpen InterestVol/OIIV
CALL$ 22.5001/20/2293$ 15.90$ 17.35$ 17.344012911.382.79%
Last Updated: Mon, 18 Oct 2021 22:39 EST

Failures to Deliver

Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.

Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.

Last Updated: Fri, 30 Jul 2021 12:00 EST


Support & Feedback

Got feedback or suggestions for more awesomeness? Or wanna keep up to date with changes?

@wsbdaily@wsbdailywsbdaily subredditwsbdaily

No obligation, if you'd like to support us with development and hosting costs then

Buy Me A Coffee

Disclaimer

WE ARE NOT AFFILIATED WITH REDDIT, THE LEADERSHIP OR MODERATOR TEAMS OF ANY OF THE SUBREDDITS WE CRAWL NOR WITH ANY OTHER WEBSITE, COMPANY OR DATA PROVIDER FROM WHICH WE PULL AND/OR AGGREGATE DATA FROM.

ALL CONTENT ON THIS SITE IS SOLEY FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY. THE SITE AND CONTENT, ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. ANY CONTENT OR STATEMENT HEREIN SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, OR AS AN OFFER TO BUY, SELL, OR SOLICIT THE PURCHASE OR SALE OF ANY SECURITY OR FINANCIAL INSTRUMENT. DO YOUR OWN DUE DILIGENCE.

THE INFORMATION ON THIS SITE IS NOT UPDATED IN REAL-TIME, EACH DATASET SPECIFIES WHEN IT WAS “LAST UPDATED”. MOST INFORMATION IS CURRENTLY INDEPENDENTLY PERIODICALLY UPDATED EVERY 30 TO 150 MINUTES AND ONLY WHEN THE MARKETS ARE CLOSED. YOU BEAR ALL RISKS ASSOCIATED WITH THE USE OF THE SITE AND CONTENT, INCLUDING WITHOUT LIMITATION, ANY RELIANCE ON THE ACCURACY, COMPLETENESS OR USEFULNESS OF ANY CONTENT AVAILABLE ON THE SITE. YOUR USE OF THE INFORMATION CONTAINED HEREIN IS SOLELY AT YOUR OWN RISK. DO YOUR OWN DUE DILIGENCE.

There are high risks associated with investing in securities. Investing in stocks, options, bonds, ETFs, mutual funds, and money market funds involve risk of substantial loss. Loss of principal is possible. Some high risk investments may use leverage, which will greatly accentuate any losses. Foreign investing involves special risks, including a greater volatility and political, economic and currency risks and differences in accounting methods. Any past investment performance is not a guarantee or predictor of future investment performance. DO YOUR OWN DUE DILIGENCE.

The software providing the content on this site is currently in an alpha state. Although care is taken to publish accurate data inaccurate information is very, very possible. Use at your own risk. DO YOUR OWN DUE DILIGENCE.